Clinical Trial Update: The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries

View source ↗

Summary

A completed clinical trial investigating soluble TREM-1 in sepsis and related acute kidney injury conditions; no results are described in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Sepsis
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: SIRS, Sepsis | Status: COMPLETED